Elicera Therapeutics (OMX: ELIC)

Last close As at 03/12/2025

SEK6.50

−0.08 (−1.22%)

Market capitalisation

SEK316m

Elicera Therapeutics is a Sweden-based clinical-stage cell and gene therapy company focused on developing next generation immuno-oncology treatments based on iTANK-armed oncolytic viruses and CAR-T cells.

Latest Insights

Sector

Healthcare

Equity Analyst

Jyoti Prakash

Jyoti Prakash, CFA

Director, healthcare

Key Management

  • Ingvar Karlsson

    CFO

  • Jamal El-Mosleh

    CEO and co-founder